Copyright Reports & Markets. All rights reserved.

Global Small Molecule Active Pharmaceutical Ingredient Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Small Molecule Active Pharmaceutical Ingredient Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size Growth Rate by Product
      • 1.4.2 Standard API
      • 1.4.3 High Potency API
    • 1.5 Market by End User
      • 1.5.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size Growth Rate by End User
      • 1.5.2 Cardiovascular Diseases
      • 1.5.3 Respiratory Disorders
      • 1.5.4 Infectious Diseases
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size
      • 2.1.1 Global Small Molecule Active Pharmaceutical Ingredient Revenue 2014-2025
      • 2.1.2 Global Small Molecule Active Pharmaceutical Ingredient Sales 2014-2025
    • 2.2 Small Molecule Active Pharmaceutical Ingredient Growth Rate by Regions
      • 2.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales by Regions
      • 2.2.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Small Molecule Active Pharmaceutical Ingredient Sales by Manufacturers
      • 3.1.1 Small Molecule Active Pharmaceutical Ingredient Sales by Manufacturers
      • 3.1.2 Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Manufacturers
      • 3.1.3 Global Small Molecule Active Pharmaceutical Ingredient Market Concentration Ratio (CR5 and HHI)
    • 3.2 Small Molecule Active Pharmaceutical Ingredient Revenue by Manufacturers
      • 3.2.1 Small Molecule Active Pharmaceutical Ingredient Revenue by Manufacturers (2014-2019)
      • 3.2.2 Small Molecule Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2014-2019)
    • 3.3 Small Molecule Active Pharmaceutical Ingredient Price by Manufacturers
    • 3.4 Small Molecule Active Pharmaceutical Ingredient Manufacturing Base Distribution, Product Types
      • 3.4.1 Small Molecule Active Pharmaceutical Ingredient Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Small Molecule Active Pharmaceutical Ingredient Product Type
      • 3.4.3 Date of International Manufacturers Enter into Small Molecule Active Pharmaceutical Ingredient Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Small Molecule Active Pharmaceutical Ingredient Sales by Product
    • 4.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue by Product
    • 4.3 Small Molecule Active Pharmaceutical Ingredient Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Small Molecule Active Pharmaceutical Ingredient Breakdown Data by End User

    6 North America

    • 6.1 North America Small Molecule Active Pharmaceutical Ingredient by Countries
      • 6.1.1 North America Small Molecule Active Pharmaceutical Ingredient Sales by Countries
      • 6.1.2 North America Small Molecule Active Pharmaceutical Ingredient Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Small Molecule Active Pharmaceutical Ingredient by Product
    • 6.3 North America Small Molecule Active Pharmaceutical Ingredient by End User

    7 Europe

    • 7.1 Europe Small Molecule Active Pharmaceutical Ingredient by Countries
      • 7.1.1 Europe Small Molecule Active Pharmaceutical Ingredient Sales by Countries
      • 7.1.2 Europe Small Molecule Active Pharmaceutical Ingredient Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Small Molecule Active Pharmaceutical Ingredient by Product
    • 7.3 Europe Small Molecule Active Pharmaceutical Ingredient by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Small Molecule Active Pharmaceutical Ingredient by Countries
      • 8.1.1 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales by Countries
      • 8.1.2 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Small Molecule Active Pharmaceutical Ingredient by Product
    • 8.3 Asia Pacific Small Molecule Active Pharmaceutical Ingredient by End User

    9 Central & South America

    • 9.1 Central & South America Small Molecule Active Pharmaceutical Ingredient by Countries
      • 9.1.1 Central & South America Small Molecule Active Pharmaceutical Ingredient Sales by Countries
      • 9.1.2 Central & South America Small Molecule Active Pharmaceutical Ingredient Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Small Molecule Active Pharmaceutical Ingredient by Product
    • 9.3 Central & South America Small Molecule Active Pharmaceutical Ingredient by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient by Countries
      • 10.1.1 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales by Countries
      • 10.1.2 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient by Product
    • 10.3 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient by End User

    11 Company Profiles

    • 11.1 Johnson Matthey
      • 11.1.1 Johnson Matthey Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Products Offered
      • 11.1.5 Johnson Matthey Recent Development
    • 11.2 Siegfried Holding AG
      • 11.2.1 Siegfried Holding AG Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Products Offered
      • 11.2.5 Siegfried Holding AG Recent Development
    • 11.3 Pfizer
      • 11.3.1 Pfizer Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Pfizer Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Pfizer Small Molecule Active Pharmaceutical Ingredient Products Offered
      • 11.3.5 Pfizer Recent Development
    • 11.4 Sanofi S.A.
      • 11.4.1 Sanofi S.A. Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Products Offered
      • 11.4.5 Sanofi S.A. Recent Development
    • 11.5 Novartis AG,
      • 11.5.1 Novartis AG, Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Products Offered
      • 11.5.5 Novartis AG, Recent Development
    • 11.6 Bristol-Myers Squibb
      • 11.6.1 Bristol-Myers Squibb Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Products Offered
      • 11.6.5 Bristol-Myers Squibb Recent Development
    • 11.7 Boehringer Ingelheim GmbH
      • 11.7.1 Boehringer Ingelheim GmbH Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Products Offered
      • 11.7.5 Boehringer Ingelheim GmbH Recent Development
    • 11.8 GlaxoSmithKline
      • 11.8.1 GlaxoSmithKline Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Products Offered
      • 11.8.5 GlaxoSmithKline Recent Development
    • 11.9 Albany Molecular Research Inc.
      • 11.9.1 Albany Molecular Research Inc. Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Products Offered
      • 11.9.5 Albany Molecular Research Inc. Recent Development
    • 11.10 Bachem Holding AG
      • 11.10.1 Bachem Holding AG Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Products Offered
      • 11.10.5 Bachem Holding AG Recent Development
    • 11.11 PCAS
    • 11.12 Patheon N.V.
    • 11.13 AstraZeneca
    • 11.14 Johnson & Johnson
    • 11.15 Merck & Co, Inc.
    • 11.16 BASF SE
    • 11.17 Catalent Inc.
    • 11.18 Teva Pharmaceuticals
    • 11.19 Roche
    • 11.20 Cambrex Corporation
    • 11.21 GILEAD Science Inc.

    12 Future Forecast

    • 12.1 Small Molecule Active Pharmaceutical Ingredient Market Forecast by Regions
      • 12.1.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Regions 2019-2025
    • 12.2 Small Molecule Active Pharmaceutical Ingredient Market Forecast by Product
      • 12.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Product 2019-2025
      • 12.2.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Product 2019-2025
    • 12.3 Small Molecule Active Pharmaceutical Ingredient Market Forecast by End User
    • 12.4 North America Small Molecule Active Pharmaceutical Ingredient Forecast
    • 12.5 Europe Small Molecule Active Pharmaceutical Ingredient Forecast
    • 12.6 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Forecast
    • 12.7 Central & South America Small Molecule Active Pharmaceutical Ingredient Forecast
    • 12.8 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Small Molecule Active Pharmaceutical Ingredient Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Small Molecule Active Pharmaceutical Ingredient market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Small Molecule Active Pharmaceutical Ingredient market based on company, product type, end user and key regions.

      This report studies the global market size of Small Molecule Active Pharmaceutical Ingredient in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Small Molecule Active Pharmaceutical Ingredient in these regions.
      This research report categorizes the global Small Molecule Active Pharmaceutical Ingredient market by top players/brands, region, type and end user. This report also studies the global Small Molecule Active Pharmaceutical Ingredient market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Johnson Matthey
      Siegfried Holding AG
      Pfizer
      Sanofi S.A.
      Novartis AG,
      Bristol-Myers Squibb
      Boehringer Ingelheim GmbH
      GlaxoSmithKline
      Albany Molecular Research Inc.
      Bachem Holding AG
      PCAS
      Patheon N.V.
      AstraZeneca
      Johnson & Johnson
      Merck & Co, Inc.
      BASF SE
      Catalent Inc.
      Teva Pharmaceuticals
      Roche
      Cambrex Corporation
      GILEAD Science Inc.

      Market size by Product
      Standard API
      High Potency API
      Market size by End User
      Cardiovascular Diseases
      Respiratory Disorders
      Infectious Diseases
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Small Molecule Active Pharmaceutical Ingredient market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Small Molecule Active Pharmaceutical Ingredient market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Small Molecule Active Pharmaceutical Ingredient companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Small Molecule Active Pharmaceutical Ingredient submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Small Molecule Active Pharmaceutical Ingredient are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Small Molecule Active Pharmaceutical Ingredient market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now